3-CPMT

CAS No. 14008-79-8

3-CPMT( Wy 2149 | FC-1 | Chlortropbenzyl hydrochloride | 3-[(4-chlorophenyl)-phenylmethoxy]-8-methyl-8-azabicyclo[3.2.1]octane hydrochloride | SL6057 )

Catalog No. M27594 CAS No. 14008-79-8

3-CPMT is a dopamine uptake inhibitor and a potent long-acting antihistaminic agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 Get Quote
5MG 61 Get Quote
10MG 88 Get Quote
25MG 213 Get Quote
50MG 404 Get Quote
100MG 593 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3-CPMT
  • Note
    Research use only, not for human use.
  • Brief Description
    3-CPMT is a dopamine uptake inhibitor and a potent long-acting antihistaminic agent.
  • Description
    3-CPMT is a dopamine uptake inhibitor and a potent long-acting antihistaminic agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Wy 2149 | FC-1 | Chlortropbenzyl hydrochloride | 3-[(4-chlorophenyl)-phenylmethoxy]-8-methyl-8-azabicyclo[3.2.1]octane hydrochloride | SL6057
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Imidazoline Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14008-79-8
  • Formula Weight
    378.34
  • Molecular Formula
    C21H25Cl2NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.CN1[C@H]2CC[C@@H]1C[C@H](C2)O[C@H](c1ccccc1)c1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Mirzaei N, et al. Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease. Br J Pharmacol. 2021 Feb;178(3):654-671.
molnova catalog
related products
  • BP14979

    BP14979 is a dopamine D3 receptor agonist that can be used to study neurological disorders.

  • 9-FLUORENOL

    9-FLUORENOL is a dopamine reuptake inhibitor with IC50 of 9 μM, and a major metabolite of a compound developed as a wakefulness-promoting agent.

  • Lensiprazine

    Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.